Tag: Cancer
-
Kolling NEWS
Posted on:
We’re kicking off the year with plenty of encouraging research news. Read on for details about new funding, fascinating research into the link between heart disease and osteoarthritis and promising work into a new diabetes treatment. We also unveil the winners of our travel awards program, generously backed by philanthropic funding. Click here: Kolling NEWS
Category:
-
Significant investment in our research announced
Posted on:
A large collection of research projects will get off the ground following generous funding through the Ramsay Research and Teaching Fund Scheme. The scheme has directed more than $10 million to research on the Royal North Shore Hospital campus over the last 20 years, and this year a further $850,000 will be shared across 17
Category:
-
Crucial funds strengthening our research expertise
Posted on:
A group of researchers will have the chance to broaden their skills and establish new collaborations following a funding boost from the Royal North Shore Hospital Scientific Staff Council. The council has awarded 12 travel grants to scientists working within the district and the Kolling Institute. The diverse group of leaders is driving research progress
Category:
-
Technology giving our researchers the edge
Posted on:
Impressive new infrastructure at the Kolling Institute is set to drive progress with our research into cancer and neuroscience. The equipment includes a digital spatial profiling system, which is regarded as one of the most exciting technological advances globally in the investigation of tissues. The $525,000 instrument has been made possible following a LIEF grant
Category:
-
Act of generosity continues to deliver hope for those with cancer
Posted on:
The Kolling Institute hosted a special visit by the family of the late Bill Walsh who donated vital funds to establish a cancer laboratory within the Kolling. His family, including his wife, daughters and grandchildren visited the lab to maintain their strong ties with the research team and meet with Academic Director Professor Jim Elliott.
Category:
-
New approach revolutionising ovarian cancer research
Posted on:
With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kolling Institute is offering hope. The disease has the lowest survival rate of any women’s cancer, with only 48 per cent of women living beyond five years after diagnosis. Ovarian cancer is often diagnosed late because the symptoms are
Category:
-
Recognition of our impact on the world stage
Posted on:
Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best. Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields. The study
Category:
-
Philanthropic funds creating travel opportunities
Posted on:
A collection of emerging research leaders will have the chance to broaden their research experience thanks to funding provided through the Skipper Jacobs Charitable Trust. Close to $40,000 will be shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally expanding their research and developing new skills. It’s anticipated the travel program
Category:
-
Kolling awards unveiled
Posted on:
We are pleased to announce the successful recipients of our annual Kolling Institute awards program. Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling. The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as
-
Researchers to join leading cancer care centres in exciting new trial
Posted on:
Researchers from the Kolling Institute and Royal North Shore Hospital will help drive a new project investigating a revolutionary approach to care for those with neuroendocrine tumours. Cancer specialists Professor Nick Pavlakis and Dr David Chan will join the AUS-NET trial after a funding announcement by Health Minister Greg Hunt. The study will assess whether
Category: